Rocket Lab Corp
RKLB Nasdaq Guided Missiles & Space Vehicles & Parts Financials FY2020βFY2025
What Rocket Lab Corp does
No business description yet.
- Legal name
- Rocket Lab Corp
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001819994-26-000013
0001819994
Revenue and margins
Rocket Lab Corp had $602M of revenue in fiscal 2025, up 38.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$322M in fiscal 2025, β53.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Rocket Lab Corp returned β to shareholders in fiscal 2025. The diluted share count rose 7.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Rocket Lab Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $691M | $472M | $245M | $419M | $1.0B |
| Debt incl. finance leases | $100M | $119M | $15.6M | $361M | $167M |
| Debt / equity | 0.1x | 0.2x | 0.0x | 0.9x | 0.1x |
| Interest coverage | β | β | β10.2x | β7.3x | β8.6x |
| Current ratio | 8.0x | 4.1x | 2.1x | 2.0x | 4.1x |
| Quick ratio | 7.5x | 3.5x | 1.7x | 1.7x | 3.6x |
| Total assets | $981M | $989M | $941M | $1.2B | $2.3B |
| Total liabilities | $282M | $316M | $387M | $802M | $603M |
| Shareholders' equity | $698M | $673M | $555M | $382M | $1.7B |
| Net debt (β = net cash) | β$591M | β$353M | β$229M | β$58.4M | β$849M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 3 / 9 | 4 / 9 | 4 / 9 | 5 / 9 |
| Accruals ratio | β14.5% | β7.8% | β3.0% | β8.7% | β13.3% | β1.9% |
| Altman Z'' | β5.86 | 5.42 | 3.18 | β0.16 | β0.86 | 3.83 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $35.2M | $62.2M | $211M | $245M | $436M | $602M |
| Gross profit | β$11.8M | β$1.9M | $19.0M | $51.4M | $116M | $207M |
| Research and development | $19.1M | $41.8M | $65.2M | $119M | $174M | $271M |
| Operating income | β$55.0M | β$102M | β$135M | β$178M | β$190M | β$229M |
| Interest expense | β | β | β | $17.5M | $26.2M | $26.5M |
| Pretax income | β$54.5M | β$125M | β$133M | β$179M | β$189M | β$226M |
| Income tax | $0.5M | β$7.5M | $3.0M | $3.7M | $0.8M | β$27.7M |
| Net income | β$55.0M | β$117M | β$136M | β$183M | β$190M | β$198M |
| Diluted EPS | β$0.73 | β$0.56 | β$0.29 | β$0.38 | β$0.38 | β$0.37 |
| Diluted shares | 0.08B | 0.21B | 0.47B | 0.48B | 0.50B | 0.53B |
| Cash flow | ||||||
| Cash from operations | β$27.8M | β$71.8M | β$107M | β$98.9M | β$48.9M | β$166M |
| Capital expenditure | $25.1M | $25.7M | $42.4M | $54.7M | $67.1M | $156M |
| Free cash flow | β$52.9M | β$97.5M | β$149M | β$154M | β$116M | β$322M |
| Depreciation and amortization | $9.3M | $10.9M | $29.9M | $29.7M | $33.7M | $43.9M |
| Stock-based compensation | $4.2M | $32.6M | $55.6M | $53.5M | $56.8M | $71.1M |
| Acquisitions | $12.2M | $66.4M | $65.8M | $19.0M | $0.0M | $132M |
| Balance sheet | ||||||
| Cash and short-term investments | $52.8M | $691M | $472M | $245M | $419M | $1.0B |
| Total debt | $0.0M | $100M | $103M | $0.0M | $345M | $152M |
| Finance lease liabilities | β | β | $15.9M | $15.6M | $15.2M | $15.0M |
| Current assets | $93.1M | $775M | $662M | $477M | $693M | $1.4B |
| Current liabilities | $48.4M | $96.3M | $163M | $223M | $340M | $334M |
| Inventory | $26.1M | $47.9M | $92.3M | $108M | $119M | $158M |
| Property and equipment, net | $49.8M | $65.3M | $102M | $145M | $195M | $319M |
| Goodwill | $3.1M | $43.3M | $71.0M | $71.0M | $71.0M | $206M |
| Intangible assets | $11.3M | $57.5M | $79.7M | $68.1M | $58.6M | $225M |
| Total assets | $188M | $981M | $989M | $941M | $1.2B | $2.3B |
| Total liabilities | $79.6M | $282M | $316M | $387M | $802M | $603M |
| Preferred stock | $0.0M | β | β | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β$167M | $698M | $673M | $555M | $382M | $1.7B |
| Margins | ||||||
| Gross margin | β33.6% | β3.0% | 9.0% | 21.0% | 26.6% | 34.4% |
| Operating margin | β156.3% | β164.0% | β64.1% | β72.7% | β43.5% | β38.0% |
| EBITDA margin | β129.7% | β146.5% | β49.9% | β60.6% | β35.8% | β30.7% |
| Net margin | β156.4% | β188.5% | β64.4% | β74.6% | β43.6% | β32.9% |
| FCF margin | β150.4% | β156.6% | β70.6% | β62.8% | β26.6% | β53.5% |
| Returns | ||||||
| Return on capital | β | β74.9% | β35.1% | β45.4% | β48.5% | β21.1% |
| Return on capital employed | β39.4% | β11.5% | β16.4% | β24.8% | β22.5% | β11.5% |
| Return on equity | β | β44.1% | β19.8% | β29.7% | β40.6% | β18.8% |
| Return on assets | β29.3% | β20.1% | β13.8% | β18.9% | β17.9% | β11.3% |
| Return on tangible equity | β | β19.6% | β26.0% | β43.9% | β75.2% | β15.3% |
| Growth | ||||||
| Revenue growth | β | 77.0% | 239.0% | 15.9% | 78.3% | 38.0% |
| Share count change | β | 178.3% | 122.1% | 3.3% | 2.9% | 7.0% |
| Financial health | ||||||
| Debt / equity | β | 0.1x | 0.2x | 0.0x | 0.9x | 0.1x |
| Interest coverage | β | β | β | β10.2x | β7.3x | β8.6x |
| Current ratio | 1.9x | 8.0x | 4.1x | 2.1x | 2.0x | 4.1x |
| Quick ratio | 1.4x | 7.5x | 3.5x | 1.7x | 1.7x | 3.6x |
| Capital allocation | ||||||
| Capex / revenue | 71.4% | 41.3% | 20.1% | 22.4% | 15.4% | 26.0% |
| Stock comp / revenue | 12.0% | 52.3% | 26.4% | 21.9% | 13.0% | 11.8% |
| Quality scores | ||||||
| Piotroski F-score | β | 4.0 | 3.0 | 4.0 | 4.0 | 5.0 |
| Altman Z'' | β5.9 | 5.4 | 3.2 | β0.2 | β0.9 | 3.8 |
| Accruals ratio | β14.5% | β7.8% | β3.0% | β8.7% | β13.3% | β1.9% |
Source: SEC EDGAR XBRL filings (CIK 0001819994). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.